As of close of business last night, Alkermes plc’s stock clocked out at $28.47, down -0.45% from its previous closing price of $28.60. In other words, the price has decreased by -$0.13 from its previous closing price. On the day, 1534722 shares were traded.
Ratios:
To gain a deeper understanding of ALKS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.15 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.46. For the most recent quarter (mrq), Quick Ratio is recorded 2.50 and its Current Ratio is at 2.86. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.30.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 27 ’24 when Parisi Samuel Joseph sold 2,559 shares for $29.65 per share. The transaction valued at 75,874 led to the insider holds 7,717 shares of the business.
LAURENCIN CATO T sold 2,690 shares of ALKS for $85,676 on Feb 15 ’24. The Director now owns 15,169 shares after completing the transaction at $31.85 per share. On Jun 08 ’23, another insider, LAURENCIN CATO T, who serves as the Director of the company, sold 2,638 shares for $31.85 each. As a result, the insider received 84,020 and left with 7,479 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALKS now has a Market Capitalization of 4.76B and an Enterprise Value of 4.36B. As of this moment, Alkermes’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.76, and their Forward P/E ratio for the next fiscal year is 11.25. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.86 while its Price-to-Book (P/B) ratio in mrq is 3.95. Its current Enterprise Value per Revenue stands at 2.62 whereas that against EBITDA is 8.38.
Stock Price History:
Over the past 52 weeks, ALKS has reached a high of $32.88, while it has fallen to a 52-week low of $20.46. The 50-Day Moving Average of the stock is 28.56, while the 200-Day Moving Average is calculated to be 28.32.
Shares Statistics:
It appears that ALKS traded 2.32M shares on average per day over the past three months and 1.6M shares per day over the past ten days. A total of 166.98M shares are outstanding, with a floating share count of 164.61M. Insiders hold about 1.47% of the company’s shares, while institutions hold 106.23% stake in the company. Shares short for ALKS as of Feb 29, 2024 were 13.02M with a Short Ratio of 5.60, compared to 11.66M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.79% and a Short% of Float of 8.89%.
Earnings Estimates
As of right now, 6 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $0.69 for the current quarter, with a high estimate of $0.92 and a low estimate of $0.58, while EPS last year was $0.01. The consensus estimate for the next quarter is $0.79, with high estimates of $0.95 and low estimates of $0.71.
Analysts are recommending an EPS of between $2.85 and $2.7 for the fiscal current year, implying an average EPS of $2.79. EPS for the following year is $2.7, with 7 analysts recommending between $3.26 and $2.35.
Revenue Estimates
In the current quarter, 7 analysts expect revenue to total $377M. It ranges from a high estimate of $415.01M to a low estimate of $366M. As of the current estimate, Alkermes plc’s year-ago sales were $287.6M, an estimated increase of 31.10% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $395.44M, a decrease of -36.00% less than the figure of $31.10% in the same quarter last year. There is a high estimate of $426.01M for the next quarter, whereas the lowest estimate is $385.67M.
A total of 10 analysts have provided revenue estimates for ALKS’s current fiscal year. The highest revenue estimate was $1.56B, while the lowest revenue estimate was $1.48B, resulting in an average revenue estimate of $1.53B. In the same quarter a year ago, actual revenue was $1.66B, down -8.00% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $1.54B in the next fiscal year. The high estimate is $1.74B and the low estimate is $1.43B. The average revenue growth estimate for next year is up 0.90% from the average revenue estimate for this year.
